UCB and Imclone Strike Antibody Alliance
By Business Review Editor
Pharma Deals Review: Vol 2005 Issue 63 (Table of Contents)
Published: 5 Sep-2005
DOI: 10.3833/pdr.v2005.i63.625 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Imclone and UCB entered into a collaboration to develop and commercialize UCB’s CDP-791 antibody for treating cancer...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS